Ronald Stern
Internal Medicine · Pomona, NYNPI 1659397651
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $913 and has fallen 95.7% since, to $40 in 2023.
Across 115 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$372
- AstraZeneca$356
- GSK$190
- Merck$170
- Novo Nordisk$166
- Pfizer$166
- plus $586 from 11 others
What the payments were for
- Food & beverage$1,90795%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 18 | $372 |
| AstraZeneca | 22 | $356 |
| GSK | 10 | $190 |
| Merck | 13 | $170 |
| Novo Nordisk | 11 | $166 |
| Pfizer | 10 | $166 |
| Lilly USA, LLC | 8 | $117 |
| Astellas Pharma US Inc | 1 | $99 |
| Arbor Pharmaceuticals, Inc. | 4 | $68 |
| Amarin Pharma, Inc. | 3 | $58 |
| Novartis | 4 | $58 |
| Alfasigma USA, Inc. | 3 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| AbbVie | 2 | $32 |
| Johnson & Johnson | 2 | $30 |
| Abbott | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
How this compares
$2,006 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 41 | $444 |
| Levothyroxine Sodium | 26 | $388 |
| Amlodipine Besylate | 44 | $311 |
| Fluticasone Propionate | 11 | $289 |
| Metoprolol Succinate | 15 | $277 |
| Rosuvastatin Calcium | 22 | $271 |
| Simvastatin | 17 | $245 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 11 | $195 |
| Omeprazole | 16 | $192 |
| Ezetimibe | 11 | $175 |
| Pantoprazole Sodium | 12 | $171 |
| Famotidine | 13 | $153 |
| Sumatriptan Succinate | 16 | $137 |
| Losartan Potassium | 12 | $133 |
| Metformin Hcl | 13 | $130 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Pomona
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.